At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job. "I was in a really dark place," said ...
Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults At 17, Israel McKenzie was so burdened by obesity that he ...
The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds. That's compared to ...
But last year, the weight-loss drug Wegovy helped him shed 110 pounds in nine months, making the rural Tennessee teen part of a surge of adolescents and young adults using diabetes and obesity ...
Use of Wegovy and Other Weight-Loss Drugs Soars Among Kids and Young Adults At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to ...
At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job. “I was in a really dark place ...
New research shows the number of 12- to 25-year-olds who used diabetes and obesity drugs such as Wegovy and Ozempic climbed from about 8,700 a month in 2020 to 60,000 a month in 2023. Overall, in ...
“I was in a really dark place,” says McKenzie, whose weight had climbed to 335 pounds on his 6-foot-1 frame, despite repeated efforts to diet and exercise. “I had given up hope.” ...
Sign up for our Metro US email newsletter to get news, updates, and local insights delivered straight to your inbox! At 17, Israel McKenzie was so burdened by obesity ...
Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job.“I was in a really dark ...